tiprankstipranks
Terumo (TRUMF)
:TRUMF
US Market

Terumo (TRUMF) Earnings Dates, Call Summary & Reports

Compare
29 Followers

Earnings Data

Report Date
May 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.13
Last Year’s EPS
0.12
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 13, 2025
|
% Change Since: -0.44%
|
Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong financial performance with record-breaking results, driven by growth in the U.S. and effective pricing strategies. While there were some onetime costs and challenges in emerging markets, the overall outlook remains positive due to substantial growth and profitability improvements.
Company Guidance
In the third quarter of the 2025 fiscal year, Terumo achieved record financial outcomes across several metrics, including revenue, operating income, adjusted operating income, and net income, driven by a 13% growth in revenue compared to the previous year. The company reported cumulative revenues of ¥772.2 billion up to the end of Q3, with significant contributions from the U.S. and Europe. Operating income and adjusted operating income reached ¥133.5 billion and ¥159.3 billion, respectively, benefiting from pricing policies and foreign exchange effects. Despite encountering a one-time cost of ¥3 billion, Terumo maintained strong profit growth, supported by improved profit margins and a notable increase in sales in the Cardiac and Vascular Company. The Blood and Cell Technologies division also contributed to the strong performance with its plasma innovation business, while foreign exchange effects added ¥10.4 billion in flows. The company remains vigilant about macroeconomic factors, such as raw material prices and U.S. tariff policies, as it continues to optimize its business structure.
Record-Breaking Financial Results
Achieved all-time highs for revenue, operating income, adjusted operating income, and net income. Revenue growth was 13% compared to the previous year, reaching ¥772.2 billion, driven by U.S. growth and foreign exchange effects.
Strong Performance Across Regions
The U.S. saw the highest growth rate among all regions with double-digit growth in local currency terms. Europe and Japan also experienced strong sales driven by demand across various sectors.
Cardiac and Vascular Company Growth
Sales and revenue grew by 8% on a local currency basis, with strong contributions from Neuro and Aortic sectors in the U.S. and China.
Positive Impact of Pricing Measures
Improved profit margins achieved through pricing policies, with positive effects seen from reimbursement price revisions in Japan and price increases overseas.
Expansion in Blood and Cell Technologies
Revenue driven by the plasma innovation business, with the Rika system installed in 70% of plasma collection centers, boosting sales and profitability.
---

Terumo (TRUMF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TRUMF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 20252025 (Q4)
0.13 / -
0.117
Feb 13, 20252025 (Q3)
0.17 / 0.16
0.13219.62% (+0.03)
Nov 07, 20242025 (Q2)
0.15 / 0.13
0.1226.79% (<+0.01)
Aug 08, 20242025 (Q1)
0.14 / 0.15
0.150.73% (+0.05)
May 14, 20242024 (Q4)
0.12 / 0.12
0.08538.41% (+0.03)
Feb 07, 20242024 (Q3)
0.13 / 0.13
0.1310.45% (<+0.01)
Nov 14, 20232024 (Q2)
0.10 / 0.12
0.07855.68% (+0.04)
Aug 09, 20232024 (Q1)
0.12 / 0.10
0.0972.26% (<+0.01)
May 15, 20232023 (Q4)
0.11 / 0.08
0.07413.79% (+0.01)
Feb 09, 20232023 (Q3)
0.12 / 0.13
0.09438.91% (+0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TRUMF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 13, 2025$18.08$19.97+10.45%
Nov 07, 2024$18.46$20.31+10.02%
Aug 08, 2024$17.60$17.600.00%
May 14, 2024$16.73$17.45+4.30%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Terumo (TRUMF) report earnings?
Terumo (TRUMF) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
    What is Terumo (TRUMF) earnings time?
    Terumo (TRUMF) earnings time is at May 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TRUMF EPS forecast?
          TRUMF EPS forecast for the fiscal quarter 2025 (Q4) is 0.13.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis